![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-desktop-header-1gif-4289.gif)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-mobgif-81230.gif)
X
01 Creative Peptides (1)
02 USP (3)
01 68291-97-4 (2)
02 73101-64-1 (1)
03 Blank (1)
01 Material Origin- Chemical Synthesis; USMCA- No; KORUS- No (2)
02 Material Origin- Chemical Synthesis; USMCA- No; KORUS- Yes (1)
03 Zonisamide is a sulfonamide anticonvulsant approved for use as an adjunctive therapy in adults with partial-onset seizures, infantile spasm, mixed seizure types of Lennox?Gastaut syndrome, myoclonic, and generalized tonic clonic seizure. More information please visit the website: http://www.creative-peptides.com/product/zonisamide-item-10-101-130-124.html (1)
01 U.S.A (4)